Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 144

1.

Effects of oseltamivir treatment on duration of clinical illness and viral shedding and household transmission of influenza virus.

Ng S, Cowling BJ, Fang VJ, Chan KH, Ip DK, Cheng CK, Uyeki TM, Houck PM, Malik Peiris JS, Leung GM.

Clin Infect Dis. 2010 Mar 1;50(5):707-14. doi: 10.1086/650458.

PMID:
20121573
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial.

Welliver R, Monto AS, Carewicz O, Schatteman E, Hassman M, Hedrick J, Jackson HC, Huson L, Ward P, Oxford JS; Oseltamivir Post Exposure Prophylaxis Investigator Group.

JAMA. 2001 Feb 14;285(6):748-54.

PMID:
11176912
[PubMed - indexed for MEDLINE]
3.

Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.

Fry AM, Goswami D, Nahar K, Sharmin AT, Rahman M, Gubareva L, Azim T, Bresee J, Luby SP, Brooks WA.

Lancet Infect Dis. 2014 Feb;14(2):109-18. doi: 10.1016/S1473-3099(13)70267-6. Epub 2013 Nov 22.

PMID:
24268590
[PubMed - indexed for MEDLINE]
4.

Does treatment with oseltamivir prevent transmission of influenza to household contacts?

Hayward A.

Clin Infect Dis. 2010 Mar 1;50(5):715-6. doi: 10.1086/650459. No abstract available.

PMID:
20121572
[PubMed - indexed for MEDLINE]
Free Article
5.

Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China.

Yu H, Liao Q, Yuan Y, Zhou L, Xiang N, Huai Y, Guo X, Zheng Y, van Doorn HR, Farrar J, Gao Z, Feng Z, Wang Y, Yang W.

BMJ. 2010 Sep 28;341:c4779. doi: 10.1136/bmj.c4779.

PMID:
20876641
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Duration of viral shedding of influenza A (H1N1) virus infection treated with oseltamivir and/or traditional Chinese medicine in China: a retrospective analysis.

Wang YG, Jiang M, Wang RB, Zha QL, Zhang SJ, Zhou GQ, Li XW, Wang YY, Lv AP.

J Tradit Chin Med. 2012 Jun;32(2):148-55.

PMID:
22876436
[PubMed - indexed for MEDLINE]
Free Article
7.

Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China.

Cao B, Li XW, Mao Y, Wang J, Lu HZ, Chen YS, Liang ZA, Liang L, Zhang SJ, Zhang B, Gu L, Lu LH, Wang DY, Wang C; National Influenza A Pandemic (H1N1) 2009 Clinical Investigation Group of China.

N Engl J Med. 2009 Dec 24;361(26):2507-17. doi: 10.1056/NEJMoa0906612. Epub 2009 Dec 9.

PMID:
20007555
[PubMed - indexed for MEDLINE]
Free Article
8.

Oseltamivir for treatment and prevention of pandemic influenza A/H1N1 virus infection in households, Milwaukee, 2009.

Goldstein E, Cowling BJ, O'Hagan JJ, Danon L, Fang VJ, Hagy A, Miller JC, Reshef D, Robins J, Biedrzycki P, Lipsitch M.

BMC Infect Dis. 2010 Jul 20;10:211. doi: 10.1186/1471-2334-10-211.

PMID:
20642862
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection.

Ling LM, Chow AL, Lye DC, Tan AS, Krishnan P, Cui L, Win NN, Chan M, Lim PL, Lee CC, Leo YS.

Clin Infect Dis. 2010 Apr 1;50(7):963-9. doi: 10.1086/651083.

PMID:
20180701
[PubMed - indexed for MEDLINE]
Free Article
10.

Effect of oseltamivir, zanamivir or oseltamivir-zanamivir combination treatments on transmission of influenza in households.

Carrat F, Duval X, Tubach F, Mosnier A, Van der Werf S, Tibi A, Blanchon T, Leport C, Flahault A, Mentré F; BIVIR study group.

Antivir Ther. 2012;17(6):1085-90. doi: 10.3851/IMP2128. Epub 2012 Jun 7.

PMID:
22910171
[PubMed - indexed for MEDLINE]
11.

Delayed oseltamivir treatment is associated with longer viral shedding of pandemic (H1N1) 2009 virus.

Leung YH, Lim WL, Wong MH, Chuang SK.

Epidemiol Infect. 2012 May;140(5):814-7. doi: 10.1017/S0950268811001415. Epub 2011 Jul 29.

PMID:
21801465
[PubMed - indexed for MEDLINE]
12.

Circulation of human influenza viruses and emergence of Oseltamivir-resistant A(H1N1) viruses in Cameroon, Central Africa.

Njouom R, Mba SA, Noah DN, Gregory V, Collins P, Cappy P, Hay A, Rousset D.

BMC Infect Dis. 2010 Mar 8;10:56. doi: 10.1186/1471-2334-10-56.

PMID:
20205961
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis.

Hayden FG, Belshe R, Villanueva C, Lanno R, Hughes C, Small I, Dutkowski R, Ward P, Carr J.

J Infect Dis. 2004 Feb 1;189(3):440-9. Epub 2004 Jan 26.

PMID:
14745701
[PubMed - indexed for MEDLINE]
Free Article
14.

Factors promoting the prolonged shedding of the pandemic (H1N1) 2009 influenza virus in patients treated with oseltamivir for 5 days.

Ryoo SM, Kim WY, Sohn CH, Seo DW, Oh BJ, Lee JH, Lee YS, Lim KS.

Influenza Other Respir Viruses. 2013 Sep;7(5):833-7. doi: 10.1111/irv.12065. Epub 2012 Dec 26.

PMID:
23279949
[PubMed - indexed for MEDLINE]
15.

Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial.

Wang C, Cao B, Liu QQ, Zou ZQ, Liang ZA, Gu L, Dong JP, Liang LR, Li XW, Hu K, He XS, Sun YH, An Y, Yang T, Cao ZX, Guo YM, Wen XM, Wang YG, Liu YL, Jiang LD.

Ann Intern Med. 2011 Aug 16;155(4):217-25. doi: 10.7326/0003-4819-155-4-201108160-00005. Erratum in: Ann Intern Med. 2012 Jan 3;156(1 Pt 1):71.

PMID:
21844547
[PubMed - indexed for MEDLINE]
16.

Comparative epidemiology of pandemic and seasonal influenza A in households.

Cowling BJ, Chan KH, Fang VJ, Lau LL, So HC, Fung RO, Ma ES, Kwong AS, Chan CW, Tsui WW, Ngai HY, Chu DW, Lee PW, Chiu MC, Leung GM, Peiris JS.

N Engl J Med. 2010 Jun 10;362(23):2175-84. doi: 10.1056/NEJMoa0911530.

PMID:
20558368
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Pandemic (H1N1) 2009 virus infection: persistent viral shedding after Oseltamivir treatment.

Kanchana S, Kanchana S, Chuntrakul C, Malathum K, Prachayangprecha S, Poovorawan Y.

J Infect. 2011 Oct;63(4):295-9. doi: 10.1016/j.jinf.2011.08.005. Epub 2011 Aug 9.

PMID:
21840339
[PubMed - indexed for MEDLINE]
18.

Oseltamivir: a review of its use in influenza.

McClellan K, Perry CM.

Drugs. 2001;61(2):263-83. Review. Erratum in: Drugs 2001;61(6):775.

PMID:
11270942
[PubMed - indexed for MEDLINE]
19.

[Ergoferon and oseltamivir in treatment of influenza: results of multicentre randomized comparative clinical trial].

Aver'ianov AV, Babkin AP, Bart BIa, Volchetskiĭ AL, Minina ES, Kozyrev OA, Kostinov MP, Petrov DV, Sel'kova EP, Putilovskiĭ MA, Nechaev VB, Epshteĭn OI, Andrianova EN.

Antibiot Khimioter. 2012;57(7-8):23-30. Russian.

PMID:
23350191
[PubMed - indexed for MEDLINE]
20.

Effectiveness of a new bioequivalent formulation of oseltamivir (Enfluvir®) on 2010-2011 seasonal influenza viruses: an open phase IV study.

Ceyhan M, Karadag Oncel E, Badur S, Ciblak MA, Alhan E, Celik US, Kurugol Z, Saz EU, Ozsurekci Y, Celik M, Parlakay AO.

Int J Infect Dis. 2012 Apr;16(4):e273-8. doi: 10.1016/j.ijid.2011.12.008. Epub 2012 Feb 5.

PMID:
22310296
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk